Literature DB >> 16621027

Pulmonary dendritic cells isolated from neonatal and adult ovine lung tissue.

Sasha J Fach1, Susan L Brockmeier, Lea Ann Hobbs, Howard D Lehmkuhl, Randy E Sacco.   

Abstract

Lung dendritic cells (DCs) are potent antigen presenting cells (APCs) that initiate and modulate the adaptive immune response upon microbial infection within the pulmonary environment. For the first time, neonatal and adult lung DCs in a large animal model were compared in these studies. Here, we isolated and identified lung DCs in both neonatal and adult sheep, a valuable experimental animal utilized in pulmonary studies of naturally occurring respiratory diseases. Neonatal lung DCs exhibited characteristic dendrites and morphology when observed by transmission electron microscopy and expressed low to moderate DEC-205, CD80/86, MHC class II and CD 14. Regardless of age, lung DCs were functionally able to endocytose FITC conjugated ovalbumin but to a lesser degree than monocyte-derived DCs. In addition, neonatal lung DCs were demonstrated to be potent stimulators of allogeneic T cell proliferation. Together, these results demonstrate that neonatal and adult lung DCs are functionally similar. It is apparent from the data presented that neonatal pulmonary DCs do not exhibit an intrinsic functional defect that would impair their ability to take up antigen and stimulate naïve T cells. These data support growing evidence that neonatal immune responses may differ from adults due to different microenvironmental influences rather than differences in dendritic cell maturation states.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621027     DOI: 10.1016/j.vetimm.2006.02.012

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

Review 1.  Neonatal mucosal immunology.

Authors:  N Torow; B J Marsland; M W Hornef; E S Gollwitzer
Journal:  Mucosal Immunol       Date:  2016-09-21       Impact factor: 7.313

Review 2.  Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments.

Authors:  Mark R Ackermann
Journal:  ILAR J       Date:  2014

3.  Live Mycobacterium avium subsp. paratuberculosis and a killed-bacterium vaccine induce distinct subcutaneous granulomas, with unique cellular and cytokine profiles.

Authors:  Liying Lei; Brandon L Plattner; Jesse M Hostetter
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

4.  Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 And IL-10 gene transcripts.

Authors:  Sasha J Fach; David K Meyerholz; Jack M Gallup; Mark R Ackermann; Howard D Lehmkuhl; Randy E Sacco
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

5.  Mesenteric lymph node cells from neonates present a prominent IL-12 response to CpG oligodeoxynucleotide via an IL-15 feedback loop of amplification.

Authors:  Stéphanie Ferret-Bernard; Sonia Lacroix-Lamandé; Aude Remot; Coralie Metton; Nelly Bernardet; Bernard Charley; Françoise Drouet; Fabrice Laurent
Journal:  Vet Res       Date:  2011-02-02       Impact factor: 3.683

6.  Cellular and molecular mechanisms underlying the strong neonatal IL-12 response of lamb mesenteric lymph node cells to R-848.

Authors:  Stéphanie Ferret-Bernard; Aude Remot; Sonia Lacroix-Lamandé; Coralie Metton; Nelly Bernardet; Françoise Drouet; Fabrice Laurent
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

Review 7.  Innate Immunity to Respiratory Infection in Early Life.

Authors:  Laura Lambert; Fiona J Culley
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

8.  Perinatal lamb model of respiratory syncytial virus (RSV) infection.

Authors:  Rachel J Derscheid; Mark R Ackermann
Journal:  Viruses       Date:  2012-10-23       Impact factor: 5.048

9.  Ontogeny and phagocytic function of baboon lung dendritic cells.

Authors:  Shanjana Awasthi; Roman Wolf; Gary White
Journal:  Immunol Cell Biol       Date:  2009-02-17       Impact factor: 5.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.